Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew J Quin"'
Autor:
Krish D. Singh, Juliette H Lanskey, Richard N. Henson, Jemma E Pitt, Mark W. Woolrich, James B. Rowe, Michael S. Perkinton, Stephen Lowe, John Isaac, Andrew J Quin, Vanessa Raymont, Yun-Ju Cheng, Ece Kocagoncu, Anna C. Nobre, Melek Karadag
IntroductionWith the pressing need to develop treatments that slow or stop the progression of Alzheimers disease, new tools are needed to reduce clinical trial duration and validate new targets for human therapeutics. Such tools could be derived from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::138a8c2be2072d10e0926a4d07d4afd1
https://doi.org/10.1101/2021.05.18.21257340
https://doi.org/10.1101/2021.05.18.21257340
Autor:
Chetan Gohil, Rukuang Huang, Evan Roberts, Mats WJ van Es, Andrew J Quinn, Diego Vidaurre, Mark W Woolrich
Publikováno v:
eLife, Vol 12 (2024)
Neural activity contains rich spatiotemporal structure that corresponds to cognition. This includes oscillatory bursting and dynamic activity that span across networks of brain regions, all of which can occur on timescales of tens of milliseconds. Wh
Externí odkaz:
https://doaj.org/article/6c9af0b201cb4325b9403f45e88f6b41
Publikováno v:
Trauma. 12:211-219
Trauma forms the second largest cause of death in children under 1 year of age. Infants form a difficult cohort of patients; their range of development, differing physiology and inability to communicate or understand treatment makes them a challenge
Autor:
Catharina Zich, Andrew J Quinn, James J Bonaiuto, George O'Neill, Lydia C Mardell, Nick S Ward, Sven Bestmann
Publikováno v:
eLife, Vol 12 (2023)
Beta oscillations in human sensorimotor cortex are hallmark signatures of healthy and pathological movement. In single trials, beta oscillations include bursts of intermittent, transient periods of high-power activity. These burst events have been li
Externí odkaz:
https://doaj.org/article/c81b206c786946afb27a5a12c89485d8
Autor:
James B Rowe, Vanessa Raymont, Yun-Ju Cheng, Anna C Nobre, Juliette Helene Lanskey, Ece Kocagoncu, Andrew J Quinn, Melek Karadag, Jemma Pitt, Stephen Lowe, Michael Perkinton, Krish D Singh, Mark Woolrich, Richard N Henson
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Introduction With the pressing need to develop treatments that slow or stop the progression of Alzheimer’s disease, new tools are needed to reduce clinical trial duration and validate new targets for human therapeutics. Such tools could be derived
Externí odkaz:
https://doaj.org/article/1c3c954621654c85a6664c81f8185711